9UV4 | pdb_00009uv4

Structure of MHV68 glycoprotein B in complex with Fab5


Experimental Data Snapshot

  • Method: ELECTRON MICROSCOPY
  • Resolution: 3.30 Å
  • Aggregation State: PARTICLE 
  • Reconstruction Method: SINGLE PARTICLE 

wwPDB Validation 3D Report Full Report

Validation slider image for 9UV4

This is version 1.3 of the entry. See complete history

Literature

A broadly protective antibody targeting gammaherpesvirus gB.

Sun, C.Xie, C.Cheng, B.Z.Jiang, Z.Y.Wu, P.H.Fang, X.Y.Li, P.L.Tian, X.S.Zhou, H.Yang, Y.L.Wang, J.Sui, S.F.Liu, Z.Zeng, M.S.

(2026) Nature 653: 190-199

  • DOI: https://doi.org/10.1038/s41586-026-10192-5
  • Primary Citation Related Structures: 
    9UV4, 9UVC, 9UY9

  • PubMed Abstract: 

    Gammaherpesvirus is a subfamily of herpesvirus, distinct phylogenetically from alpha- and betaherpesvirus and featured by its oncogenic subtypes, including Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus 1 . It broadly infects humans and other vertebrate animals and causes various diseases and malignancies 2,3 . However, no specific antiviral agents are available for each type or the whole family. gB is the common fusion protein vital for herpesvirus infection and an ideal target for broad vaccine development, while the lack of basis for gB as a universal antigen hinders such effort 4 . Here, we report the molecular basis for broad gB binding and cross-genus virus neutralization by an antibody Fab5 for the first time. This antibody confers effective protection against authentic virus challenges in immune-competent mice, non-human primates, and humanized mice with murine, rhesus, and human gammaherpesvirus. Cryo-EM structures revealed that Fab5 targeted a conservative and vulnerable epitope of gammaherpesvirus gB and antigenically exposed across pre- or post-fusion status. This finding not only demonstrates Fab5 as cross-genus antibody broadly reactive against gammaherpesvirus infection and pathogenesis progression, but offers insights into potential common mechanisms for herpesvirus infection and facilitates the development of broad-spectrum vaccines against the gammaherpesvirus.


  • Organizational Affiliation
    • State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China. suncong@sysucc.org.cn.

Macromolecule Content 

  • Total Structure Weight: 367.14 kDa 
  • Atom Count: 15,814 
  • Modeled Residue Count: 2,280 
  • Deposited Residue Count: 3,285 
  • Unique protein chains: 3

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Fab 5 H chainA [auth I],
C [auth J],
E [auth K]
224Mus musculusMutation(s): 0 
Find similar proteins by:|  3D Structure
Entity ID: 2
MoleculeChains  Sequence LengthOrganismDetailsImage
Fab5 L chainB [auth M],
D [auth N],
F [auth O]
213Mus musculusMutation(s): 0 
Find similar proteins by:|  3D Structure
Entity ID: 3
MoleculeChains  Sequence LengthOrganismDetailsImage
MHV 68 glycoprotein BG [auth A],
H [auth B],
I [auth C]
658Murid herpesvirus 68Mutation(s): 0 

Experimental Data & Validation

Experimental Data

  • Method: ELECTRON MICROSCOPY
  • Resolution: 3.30 Å
  • Aggregation State: PARTICLE 
  • Reconstruction Method: SINGLE PARTICLE 

Structure Validation

View Full Validation Report



Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Natural Science Foundation of China (NSFC)China82030046

Revision History  (Full details and data files)

  • Version 1.0: 2026-01-21
    Type: Initial release
  • Version 1.1: 2026-02-18
    Changes: Data collection, Database references
  • Version 1.2: 2026-04-08
    Changes: Data collection, Structure summary
  • Version 1.3: 2026-05-20
    Changes: Data collection, Database references